USANA Health Sciences (NYSE:USNA) Sets New 52-Week Low – What’s Next?

USANA Health Sciences, Inc. (NYSE:USNA)’s stock price reached a new 52-week low during mid-day trading on Friday . The company traded as low as $34.08 and last traded at $34.08, with a volume of 22108 shares changing hands. The stock had previously closed at $34.71.

Analyst Ratings Changes

Several research analysts have weighed in on the company. StockNews.com raised USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research report on Thursday. DA Davidson upgraded shares of USANA Health Sciences to a “hold” rating in a report on Friday.

USANA Health Sciences Stock Down 3.8 %

The business has a fifty day moving average of $37.91 and a 200 day moving average of $40.37. The firm has a market cap of $636.22 million, a P/E ratio of 11.80, a PEG ratio of 1.25 and a beta of 0.89.

USANA Health Sciences (NYSE:USNA) last issued its earnings results on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, topping the consensus estimate of $0.49 by $0.07. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The company had revenue of $200.22 million during the quarter, compared to the consensus estimate of $208.45 million. During the same period in the previous year, the company posted $0.59 EPS. Research analysts expect that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Insider Transactions at USANA Health Sciences

In other news, Director Gilbert A. Fuller sold 675 shares of the stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $37.71, for a total transaction of $25,454.25. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.33% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in USNA. Exchange Traded Concepts LLC boosted its position in shares of USANA Health Sciences by 4.4% in the third quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company’s stock valued at $292,000 after acquiring an additional 322 shares during the period. Martingale Asset Management L P boosted its holdings in USANA Health Sciences by 2.1% in the 3rd quarter. Martingale Asset Management L P now owns 16,732 shares of the company’s stock valued at $634,000 after purchasing an additional 340 shares during the period. KBC Group NV boosted its holdings in USANA Health Sciences by 96.6% in the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock valued at $40,000 after purchasing an additional 519 shares during the period. Safe Harbor Fiduciary LLC acquired a new position in shares of USANA Health Sciences during the 3rd quarter worth approximately $30,000. Finally, Public Sector Pension Investment Board increased its holdings in shares of USANA Health Sciences by 5.4% during the second quarter. Public Sector Pension Investment Board now owns 24,270 shares of the company’s stock worth $1,098,000 after purchasing an additional 1,242 shares during the period. 54.25% of the stock is owned by institutional investors and hedge funds.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.